Developmental and Genetic Regulation of Human Surfactant Protein B in vivo

Background: Genetic and developmental disruption of surfactant protein B (SP-B) expression causes neonatal respiratory distress syndrome (RDS). Objectives: To assess developmental and genetic regulation of SP-B expression in vivo. Methods: To evaluate in vivo developmental regulation of SP-B, we used immunoblotting to compare frequency of detection of mature and pro-SP-B peptides in developmentally distinct cohorts: 24 amniotic fluid samples, unfractionated tracheal aspirates from 101 infants ≥34 weeks’ gestation with (75) and without (26) neonatal RDS, and 6 nonsmoking adults. To examine genetic regulation, we used univariate and logistic regression analyses to detect associations between common SP-B (SFTPB) genotypes and SP-B peptides in the neonatal RDS cohort. Results: We found pro-SP-B peptides in 24/24 amniotic fluid samples and in 100/101 tracheal aspirates from newborn infants but none in bronchoalveolar lavage from normal adults (0/6) (p < 0.001). We detected an association (p = 0.0011) between pro-SP-B peptides (Mr 40 and 42 kDa) and genotype of a nonsynonymous single nucleotide polymorphism at genomic position 1580 that regulates amino-terminus glycosylation. Conclusions: Pro-SP-B peptides are more common in developmentally less mature humans. Association of genotype at genomic position 1580 with pro-SP-B peptides (Mr 40 and 42 kDa) suggests genetic regulation of amino terminus glycosylation in vivo.

[1]  B. Kramer.  The respiratory distress syndrome (RDS) in preterm infants , 2007 .

[2]  C. Carlson,et al.  Comprehensive Genetic Variant Discovery in the Surfactant Protein B Gene , 2007, Pediatric Research.

[3]  S. Sinha,et al.  Evolution of pulmonary surfactants for the treatment of neonatal respiratory distress syndrome and paediatric lung diseases , 2006, Acta paediatrica.

[4]  T. Rice,et al.  Genetic variant characterization in intron 4 of the surfactant protein B gene , 2005, Human mutation.

[5]  S. Guttentag,et al.  Expression profiles of hydrophobic surfactant proteins in children with diffuse chronic lung disease , 2005, Respiratory research.

[6]  R. Clark.  The Epidemiology of Respiratory Failure in Neonates Born at an Estimated Gestational Age of 34 Weeks or More , 2005, Journal of Perinatology.

[7]  W. Truog,et al.  Dysfunction of Pulmonary Surfactant in Chronically Ventilated Premature Infants , 2004, Pediatric Research.

[8]  J. Johansson,et al.  Processing of Pulmonary Surfactant Protein B by Napsin and Cathepsin H* , 2004, Journal of Biological Chemistry.

[9]  K. Müller,et al.  Surfactant protein B in type II pneumocytes and intra-alveolar surfactant forms of human lungs. , 2004, American journal of respiratory cell and molecular biology.

[10]  S. Guttentag,et al.  Pepsinogen C: a type 2 cell-specific protease. , 2004, American journal of physiology. Lung cellular and molecular physiology.

[11]  K. Müller,et al.  Involvement of Napsin A in the C- and N-terminal Processing of Surfactant Protein B in Type-II Pneumocytes of the Human Lung* , 2003, Journal of Biological Chemistry.

[12]  W. Truog,et al.  Surfactant protein profile of pulmonary surfactant in premature infants. , 2003, American journal of respiratory and critical care medicine.

[13]  J. Tichelaar,et al.  SP-B deficiency causes respiratory failure in adult mice. , 2003, American journal of physiology. Lung cellular and molecular physiology.

[14]  N. Christensen,et al.  Differences in N-linked glycosylation between human surfactant protein-B variants of the C or T allele at the single-nucleotide polymorphism at position 1580: implications for disease. , 2003, The Biochemical journal.

[15]  S. Guttentag,et al.  Cysteine protease activity is required for surfactant protein B processing and lamellar body genesis. , 2003, American journal of respiratory cell and molecular biology.

[16]  K. Ikeda,et al.  Different expression of surfactant protein B mature peptide and proprotein at 21 weeks’ gestation in human fetal pulmonary epithelial cells , 2002, Pediatrics international : official journal of the Japan Pediatric Society.

[17]  A. Jobe,et al.  Injury, inflammation, and remodeling in fetal sheep lung after intra-amniotic endotoxin. , 2002, American journal of physiology. Lung cellular and molecular physiology.

[18]  B. Hills.  Surface‐active phospholipid: a Pandora’s box of clinical applications. Part I. The lung and air spaces , 2002, Internal medicine journal.

[19]  G. Clermont,et al.  Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. , 2001, American journal of respiratory and critical care medicine.

[20]  A. Jobe,et al.  Intra-amniotic endotoxin increases pulmonary surfactant proteins and induces SP-B processing in fetal sheep. , 2001, American journal of physiology. Lung cellular and molecular physiology.

[21]  T. Weaver,et al.  Function of surfactant proteins B and C. , 2001, Annual review of physiology.

[22]  S. Guttentag,et al.  Intracellular Localization of Processing Events in Human Surfactant Protein B Biosynthesis* , 2000, The Journal of Biological Chemistry.

[23]  S. Guttentag,et al.  Surfactant protein B processing in human fetal lung. , 1998, American journal of physiology. Lung cellular and molecular physiology.

[24]  A. Jobe,et al.  Rescue of SP-B Knockout Mice with a Truncated SP-B Proprotein , 1997, The Journal of Biological Chemistry.

[25]  Sui Lin,et al.  Structural Requirements for Targeting of Surfactant Protein B (SP-B) to Secretory Granules in Vitro and in Vivo* , 1996, The Journal of Biological Chemistry.

[26]  H. Colten,et al.  A mutation in the surfactant protein B gene responsible for fatal neonatal respiratory disease in multiple kindreds. , 1994, The Journal of clinical investigation.

[27]  D. Richardson,et al.  Racial differences in predictive value of the lecithin/sphingomyelin ratio. , 1994, American journal of obstetrics and gynecology.

[28]  J. Dudenhausen,et al.  Determination of the pulmonary surfactant-associated protein SP-B in amniotic fluid with a competition ELISA. , 1994, Gynecologic and obstetric investigation.

[29]  A. Hamvas,et al.  Surfactant therapy failure identifies infants at risk for pulmonary mortality. , 1993, American journal of diseases of children.

[30]  H. Colten,et al.  Brief report: deficiency of pulmonary surfactant protein B in congenital alveolar proteinosis. , 1993, The New England journal of medicine.

[31]  J. Whitsett,et al.  The ontogeny and distribution of surfactant protein B in human fetuses and newborns. , 1992, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.